Novartis : The SEC Form SD and Conflict Minerals Report 2022
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED...
Source: marketscreener.com
Retail Generics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Retail Generics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Retail Generics Today - Breaking & Trending Today
Novartis Stock: Undervalued Swiss Pharma Giant (NYSE:NVS)
Novartis trades at a discount to the global pharma sector of at least 20%. Click here to read NVS stock's valuation analysis and my price target.
Source: seekingalpha.com
Nob Hill Therapeutics Announces Strategic Advisory Board to Accelerate Growth
Albuquerque, NM (PRWEB) November 22, 2021 -- Nob Hill Therapeutics (NHT) is pleased to announce the members of its Strategic Advisory Board. Under the
Source: prweb.com
Novartis Pharma AG: Novartis delivered strong Q2 performance, driven by momentum of key growth brands. FY 2021 guidance unchanged.
Novartis Pharma AG: Novartis delivered strong Q2 performance, driven by momentum of key growth brands. FY 2021 guidance unchanged. Net sales in Q2 grew +9% (cc¹, +14% USD): Pharmaceuticals BU grew +12% (cc, +18% USD) with continued strong growth from Entresto (+46% cc), Oncology BU grew +7% (cc, +11% USD) driven by Promacta/Revolade (+18% cc), Sandoz grew +5% (cc, +11% USD) as the business is starting to stabilize Excluding prior year forward purchasing de-stocking, we estimate Q2 net sales grew +5% (cc, +10% USD), Innovative Medicines grew +7% (cc, +11% USD) and Sandoz declined -1% (cc...
Source: finanznachrichten.de